SCHEMBL29725812

SCHEMBL29725812

CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccncc4)cc23)c1F

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 10/20 0.85
BRAF P15056 3/20 0.84
CYP3A4 P08684 2/20 0.84
RIPK2 O43353 2/20 0.84
RAF1 P04049 2/20 0.84
KDR P35968 2/20 0.84
MAP2K2 P36507 2/20 0.84
TGFBR2 P37173 2/20 0.84
NEK2 P51955 2/20 0.84
MAP2K1 Q02750 2/20 0.84
TNK2 Q07912 2/20 0.84
MAP2K5 Q13163 2/20 0.84
PTK6 Q13882 2/20 0.84
NEK11 Q8NG66 2/20 0.84
MAP3K20 Q9NYL2 2/20 0.84
MAP4K5 Q9Y4K4 2/20 0.84
ABCB11 O95342 1/20 0.84
EGFR P00533 1/20 0.84
KRAS P01116 1/20 0.84
PGR P06401 1/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL298379 1.00 CYP2C9 (0.85) CYP2C9BRAFCYP3A4RIPK2RAF1
SCHEMBL20399263 0.92 CYP2C9 (0.83) CYP2C9BRAFCYP3A4RIPK2RAF1
SCHEMBL298927 0.92 BRAF (0.89) CYP2C9BRAFCYP3A4RIPK2RAF1
SCHEMBL299099 0.92 BRAF (0.86) CYP2C9BRAFCYP3A4RIPK2RAF1
SCHEMBL292477 0.92 CYP2C9 (1.00) CYP2C9BRAFCYP3A4RIPK2RAF1
SCHEMBL298373 0.92 BRAF (0.87) CYP2C9BRAFCYP3A4RIPK2RAF1
Vemurafenib SCHEMBL29355460 0.92 BRAF (1.00) CYP2C9BRAFCYP3A4RIPK2RAF1
SCHEMBL294126 0.92 CYP2C9 (1.00) CYP2C9BRAFCYP3A4RIPK2RAF1
SCHEMBL855840 0.92 BRAF (0.87) CYP2C9BRAFCYP3A4RIPK2RAF1
Vemurafenib SCHEMBL29356185 0.92 BRAF (1.00) CYP2C9BRAFCYP3A4RIPK2RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3571200-B1 PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH HEPAREGENIX GMBH (DE) 2022-06-22 EP disclosed